Table 2.
Laboratory Data on Admission 2.
| Immunological | |||
| Immunoglobulin G | 1,133 | mg/dL | |
| Immunoglobulin A | 329 | mg/dL | |
| Immunoglobulin M | 84 | mg/dL | |
| Complement C3 | 112 | mg/dL (73-138) | |
| Complement C4 | 35 | mg/dL (11-31) | |
| Complement C1q | <1.5 | /μL | |
| Anti-nuclear antibody | 1:1280 | (Centromere pattern) (<40) | |
| Anti-double-stranded deoxyribonucleic acid antibody | 1.7 | IU/mL (0-12.0) | |
| Anti-single-stranded deoxyribonucleic acid antibody | 1.9 | AU/mL (0-25.0) | |
| Anti-Sm antibody | 0.2 | U/mL (0-9.9) | |
| Anti-Sjögren’s-syndrome-related antigen A | 0.5 | U/mL (0-9.9) | |
| Anti-Sjögren’s-syndrome-related antigen B | 0.5 | U/mL (0-9.9) | |
| Anti-Scl-70 antibody | <5 | U/mL (<16) | |
| Anti-centromere antibody | 128 | U/mL (<10) | |
| Anti-Mi-2 antibody | <5 | (<53) | |
| Anti-aminoacyl-tRNA synthetase antibody | <5 | (<25) | |
| Anti-melanoma differentiation-associated gene 5 antibody | 5 | (<32) | |
| Rheumatoid factor | 118 | IU/mL (<15) | |
| Anti-cyclic citrullinated peptide antibody | 0.5 | U/mL (<4.5) | |
| Myeloperoxidase anti-neutrophil cytoplasmic antibody | 164.3 | U/mL (<3.5) | |
| Proteinase 3 anti-neutrophil cytoplasmic antibody | 4.1 | U/mL (<3.5) | |
| Antimitochondrial antibody | <20 | (<20) | |
| Soluble interleukin-2 receptor | 825 | U/mL (121-613) | |
| Tuberculosis interferon gamma release assay (T-SPOT.TB) | negative | ||
| Anti-glycopeptidolipid-core IgA antibody | <0.5 | U/mL (<0.7) | |
Numbers in parentheses indicate normal range. tRNA: transfer ribonucleic acid